AI Meets Gene Editing: the Path to Plug-and-Play Drug Development
4 Articles
4 Articles
Groundbreaking Biological “Artificial Intelligence” System Could Make Impossible Medicines Real
Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine. Australian researchers, including those at the Charles Perkins Centre at the University of Sydney, have created a groundbreaking system that uses what they describe as "biologi
AI Meets Gene Editing: the Path to Plug-and-Play Drug Development
AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process. The post AI Meets Gene Editing: the Path to Plug-and-Play Drug Development appeared first on MedCity News.
Mediafax The system has been developed by scientists from the University of Sydney. Proteus is based on the controlled evolution, a laboratory process that simulates natural evolution, but very fast. While natural evolution can take years, Proteus develops new molecules in just a few weeks, according to Sitech Daily. The news is that, apart from existing technologies that work in bacteria, Proteus can generate molecules directly in mammals. This…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium